RIGL insider buying and SEC filings, explained
Rigel Pharmaceuticals Inc. · CIK 1034842
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- RIGEL PHARMACEUTICALS INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$160K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 22, 2026 | Planned (10b5-1) | Kamil Ali-Jackson (Director) sold 2,500 shares at $35.00 ($88K), marked as a 10b5-1 plan trade. Holdings down 20% to 10,125 shares. | SEC filing Filed Jun 24, 2026 |
| May 26, 2026 | Planned (10b5-1) | Kamil Ali-Jackson (Director) sold 2,500 shares at $29.17 ($73K), marked as a 10b5-1 plan trade. Holdings down 17% to 12,625 shares. | SEC filing Filed May 28, 2026 |
40 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RIGL in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.